Search

everythinglearnresearchcommunity

for

Search:↓

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Certain natural compounds called terpenes may help prevent prostate cancer.

Taking finasteride before surgery reduces blood loss in prostate procedures.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Thermobalancing Therapy can treat enlarged prostate and improve men's quality of life.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Adherence to finasteride treatment for prostate issues is generally low.

Serenoa repens may help with prostate issues, but more research is needed to confirm its effectiveness.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

Androgen signaling reduces Wnt activity, affecting prostate stem cell growth.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

The new method found new shared genetic areas linked to both Type 2 Diabetes and Prostate Cancer.

Exposure to low doses of finasteride in the womb causes changes in the prostate of both male and female gerbils.